Close Menu

NEW YORK – A trio of companies is currently undertaking an evaluation of home-use antibody tests for SARS-CoV-2 infection, with an emphasis on behavioral outcomes. Radish Health, ProofPilot, and Sanesco have set out to demonstrate not only whether people are able to safely and effectively administer their own serology testing at home, but also whether there are behavioral consequences of home testing for COVID-19.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.